Methodology of Phase II Clinical Trial in Cancer
- 1 January 1980
- book chapter
- Published by Springer Nature
- Vol. 70, 53-60
- https://doi.org/10.1007/978-3-642-81392-4_5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Small-Cell Carcinoma of the Lung: Combined Chemotherapy and RadiationAnnals of Internal Medicine, 1978
- Clinical trials in cancer chemotherapyCancer, 1977
- Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustardCancer, 1976
- Cancer Treatment Today and Its Impact on Drug Development, With Special Emphasis on the Phase II Clinical TrialJNCI Journal of the National Cancer Institute, 1976
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- The effect of measuring error on the results of therapeutic trials in advanced cancerCancer, 1976
- Response and survival in advanced breast cancer after two non-cross-resistant combinations.BMJ, 1976
- An analysis of a multiple‐drug program in the treatment of patients with advanced breast cancer utilizing 5‐fluorouracil, cyclophosphamide, and prednisone with or without vincristineCancer, 1975
- The feasibility of using randomization schemes early in the clinical trials of new chemotherapeutic agents: Hydroxyurea (NSC‐32065)Clinical Pharmacology & Therapeutics, 1965
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961